Enantiopure substituted pyridines as promising antimalarial drug candidates

被引:10
|
作者
Bentzinger, Guillaume [1 ]
Pair, Etienne [1 ]
Guillon, Jean [2 ]
Marchivie, Mathieu [3 ]
Mullie, Catherine [1 ]
Agnamey, Patrice [1 ]
Dassonville-Klimpt, Alexandra [1 ]
Sonnet, Pascal [1 ]
机构
[1] Univ Picardie Jules Verne, AGIR Agents Infect Resistance & Chimiotherapie, UR 4294, UFR Pharm, 1 Rue Louvels, F-80037 Amiens 1, France
[2] Univ Bordeaux, Lab ARNA, UFR Sci Pharmaceut, INSERM U1212,UMR CNRS 5320, 146 Rue Leo Saignat, F-33076 Bordeaux, France
[3] Univ Bordeaux, ICMCB, Bordeaux INP, CNRS,UMR 5026, F-33600 Pessac, France
关键词
Malaria; P; falciparum; Arylaminoalcohols; Enpiroline; Asymmetric synthesis; PLASMODIUM-FALCIPARUM; MEFLOQUINE; ENANTIOMERS; EFFICACY; INVITRO; ASSAY;
D O I
10.1016/j.tet.2020.131088
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
We describe the enantioselective synthesis and biological evaluation of 4-(2-amino-l-hydroxyethyl) pyridines (4 AHPs) as new antimalarial drug candidates. In particular, two routes to obtain the key-intermediate 4-vinyl-pyridine were studied. These routes are based on a Krohnke-type cyclization or on metal-catalyzed reactions. The Krohnke-type cyclization route is faster but only efficient at low scale since this pathway involves a Wittig reaction that requires severe temperature-control. Consequently, we designed a second route based on metal-catalyzed reactions. This way is longer but the 4-vinyl-pyridine can be obtained on a 5 g scale at least. Finally, a regioselective S(N)2 ring-opening of enantiopure epoxides by alkyl primary amines allowed the synthesis of eight 4-AHPs with global yields up to 41%. These compounds show strong in vitro antimalarial activity against P. falciparum strains and are more active that chloroquine and mefloquine. These results demonstrate that 4-AHPs are promising antimalarial drug candidates. (C) 2020 Elsevier Ltd. All rights reserved.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Coumarin hybrids for targeted therapies: A promising approach for potential drug candidates
    Zeki, Nameer Mazin
    Mustafa, Yasser Fakri
    PHYTOCHEMISTRY LETTERS, 2024, 60 : 117 - 133
  • [32] Drug repurposing for COVID-19: Approaches, challenges and promising candidates
    Ng, Yan Ling
    Salim, Cyrill Kafi
    Chu, Justin Jang Hann
    PHARMACOLOGY & THERAPEUTICS, 2021, 228
  • [33] Vasoactive Thiomethyl-Pyrimidines: Promising Drug Candidates with Vascular Activity
    de Andrade, Audrey N.
    Araujo, Alice V.
    Barbosa, Hugo B. W.
    Wanderley, Almir G.
    Malta, Oscar L.
    dos Anjos, Janaina V.
    JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY, 2017, 28 (07) : 1266 - 1273
  • [34] Natural products as promising drug candidates for the treatment of hepatitis B and C
    Wohlfarth, Carolin
    Efferth, Thomas
    ACTA PHARMACOLOGICA SINICA, 2009, 30 (01) : 25 - 30
  • [35] Promising Acinetobacter baumannii Vaccine Candidates and Drug Targets in Recent Years
    Tan, Yong Chiang
    Lahiri, Chandrajit
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [36] A promising pipeline of preclinical drug candidates for leishmaniasis and chronic Chagas' disease
    Saldivia, Manuel
    Lima, Ana Paula C. A.
    Mottram, Jeremy C.
    TRENDS IN PARASITOLOGY, 2024, 40 (03) : 211 - 213
  • [37] PERMEABILITY OF ANTIMALARIAL DRUG CANDIDATES USING CACO-2 AND MDCK CELL LINES
    Jin, Xiannu
    Collazo, Vanessa
    Thu Lan Luong
    Reese, NeCole
    Pybus, Brandon S.
    Sousa, Jason
    Carroll, Dustin
    Asher, Constance
    Olmeda, Raul
    Kozar, Michael P.
    Melendez, Victor
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2010, 83 (05): : 76 - 76
  • [38] Promising antimalarial combination highlighted
    Sharp, D
    LANCET, 1996, 348 (9041): : 1575 - 1575
  • [39] In silico studies of 2,5-disubstituted furans as active antimalarial drug candidates
    Aliyu Wappah Mahmud
    Gideon Adamu Shallangwa
    Adamu Uzairu
    Bulletin of the National Research Centre, 44 (1)
  • [40] The Potential of 2-Substituted Quinolines as Antileishmanial Drug Candidates
    Loiseau, Philippe M.
    Balaraman, Kaluvu
    Barratt, Gillian
    Pomel, Sebastien
    Durand, Remy
    Frezard, Frederic
    Figadere, Bruno
    MOLECULES, 2022, 27 (07):